The Editorial Process

A manuscript will be reviewed for possible publication with the understanding that it is being submitted to International Journal of Bioinformatics and Biological Sciences alone at that point in time and has not been published anywhere, simultaneously submitted, or already accepted for publication elsewhere. The journal expects that authors would authorize one of them to correspond with the Journal for all matters related to the manuscript. All manuscripts received are duly acknowledged. On submission, editors review all submitted manuscripts initially for suitability for formal review. Manuscripts with insufficient originality, serious scientific or technical flaws, or lack of a significant message are rejected before proceeding for formal peer-review. Manuscripts that are unlikely to be of interest to the International Journal of Bioinformatics and Biological Sciences readers are also liable to be rejected at this stage itself.


Manuscripts that are found suitable for publication in International Journal of Bioinformatics and Biological Sciences are sent to two or more expert reviewers. During submission, the contributor is requested to provide names of two or three qualified reviewers who have had experience in the subject of the submitted manuscript, but this is not mandatory. The reviewers should not be affiliated with the same institutes as the contributor/s. However, the selection of these reviewers is at the sole discretion of the editor. The journal follows a double-blind review process, wherein the reviewers and authors are unaware of each other’s identity. Every manuscript is also assigned to a member of the editorial team, who based on the comments from the reviewers takes a final decision on the manuscript. The comments and suggestions (acceptance/ rejection/ amendments in manuscript) received from reviewers are conveyed to the corresponding author. If required, the author is requested to provide a point by point response to reviewers’ comments and submit a revised version of the manuscript. This process is repeated till reviewers and editors are satisfied with the manuscript.


Manuscripts accepted for publication are copy edited for grammar, punctuation, print style, and format. Page proofs are sent to the corresponding author. The corresponding author is expected to return the corrected proofs within a week’s time. It may not be possible to incorporate corrections received after that period. The whole process of submission of the manuscript to final decision and sending and receiving proofs is completed online. To achieve faster and greater dissemination of knowledge and information, the journal publishes articles online as ‘Ahead of Print’ immediately on acceptance.

Duplicate Submission and Redundant Publication

International Journal of Bioinformatics and Biological Sciences follow closely ethical instructions provided by the medical and health industries and/or associations, which are the International Committee of Medical Journal Editors (ICMJE), World Association of Medical Editors (WAME) and Committee on Publication Ethics (COPE), have set standards and provide guidelines for best writing literature and practices in order to meet these requirements for a journal and editor. Manuscripts that are not submitted in fulfillment with our journal instructions and guidelines are more likely to be rejected. The manuscript, including the title page, abstract and keywords, text, references, figure captions, and tables should be typewritten, double-spaced in 12-point font with 1-inch margins all around and saved as one file.


Redundant publication, the inappropriate division of study outcomes into more than one article (also known as salami slicing or salami publications), may result in rejection or a request to merge submitted manuscripts, and the correction of published articles. Duplicate publication of the same, citation manipulation, fabrication or falsification or a very similar, article may result in the retraction of the later article and the authors may incur sanctions.

Conflicts of Interest/ Competing Interests

All authors of must disclose any and all conflicts of interest they may have with publication of the manuscript or an institution or product that is mentioned in the manuscript and/or is important to the outcome of the study presented. Authors should also disclose conflict of interest with products that compete with those mentioned in their manuscript.

Submission of Manuscripts :

All manuscripts must be submitted on-line through the website https://manuscriptsubmissionweb.com. First time users will have to register at this site. Registration is free but mandatory. Registered authors can keep track of their articles after logging into the site using their user name and password.


The journal does not charge for submission and processing of the manuscripts.


If you experience any problems, please contact the editorial office by e-mail at editor@ intbioinformaticsjr.com .


The submitted manuscripts that are not as per the “Instructions to Authors” would be returned to the authors for technical correction, before they undergo editorial/ peer-review.


Generally, the manuscript should be submitted must have the following:



1. The type of manuscript (original article, case report, review article, Letter to editor, Images, etc.) title of the manuscript, running title, names of all authors/ contributors (with their highest academic degrees, designation and affiliations) and name(s) of department(s) and/ or institution(s) to which the work should be credited, should be mention in the title page /front page of the manuscript .


2. Source(s) of support in the form of grants, equipment, drugs, or all of these.


3. Conflicts of Interest of each author/ contributor. A statement of financial or other relationships that might lead to a conflict of interest, if that information is not included in the manuscript itself or in an authors' form.


4. Criteria for inclusion in the authors’/ contributors’ list.


5. The name, address, e-mail, and telephone number of the corresponding author, who is responsible for communicating with the other authors about revisions and final approval of the proofs, if that information is not included on the manuscript itself.


In the Article:

1. The main text of the article, beginning from Abstract till References (including tables) should be in this file. The file must not contain any mention of the authors' names or initials or the institution at which the study was done or acknowledgements. Page headers/running title can include the title but not the authors' names. Manuscripts not in compliance with the Journal's blinding policy will be returned to the corresponding author. Use rtf/doc files. Do not zip the files. Limit the file size to 1 MB. Do not incorporate images in the file. If file size is large, graphs can be submitted as images separately without incorporating them in the article file to reduce the size of the file. The pages should be numbered consecutively, beginning with the first page of the blinded article file.


Images:

Submit good quality color images. Each image should be less than 2 MB in size. Size of the image can be reduced by decreasing the actual height and width of the images (keep up to 1600 x 1200 pixels or 5-6 inches). Images can be submitted as jpeg files. Do not zip the files. Legends for the figures/images should be included at the end of the article file.


The Contributors' / Copyright form

It has to be submitted in original with the signatures of all the contributors during the submission of the manuscript. Without Copyright form, article will not be accepted.


Contributors’ form / copyright transfer form can be downloaded online from the authors’ area on https://intbioinformaticsjr.com/Journal/copyrightForm

Preparation of Manuscripts

Manuscripts must be prepared in accordance with "Uniform requirements for Manuscripts submitted to Biomedical Journals" developed by the International Committee of Medical Journal Editors (October 2008). The uniform requirements and specific requirement of International Journal of Bioinformatics and Biological Sciences are summarized below.


Before submitting a manuscript, contributors are requested to check for the latest instructions available.


International Journal of Bioinformatics and Biological Sciences accept manuscripts written in American English.

Copies of any permission(s)

It is the responsibility of authors/ contributors to obtain permissions for reproducing any copyrighted material. A copy of the permission obtained must accompany the manuscript. Copies of any and all published articles or other manuscripts in preparation or submitted elsewhere that are related to the manuscript must also accompany the manuscript.

Types of Manuscripts

Original articles: The text of original articles amounting to up to 3000 words (excluding Abstract, references and Tables) should be divided into sections with the headings Abstract, Key-words, Introduction, Material and Methods, Results, Discussion, References, Tables and Figure legends.


Review articles : The manuscript should have an Abstract (250 words) representing an accurate summary of the article. The section titles would depend upon the topic reviewed. Authors submitting review article should include a section describing the methods used for locating, selecting, extracting, and synthesizing data. These methods should also be summarized in the abstract.


Case reports or briefs: Novel/interesting/extremely rare cases or rare presentations can be reported. Cases with clinical significance or implications will be given priority. Up to 1200 words excluding references and abstract and up to 10-15 references.


Case Series: Same as case report more than two case reports having similar findings.


Author should consult the Check List for authors (given separately) before submission of article.


Title: The title should be brief, concise, and call attention to the main point of the article. With a few exceptions, abbreviations and acronyms must be written out in full in titles.(Font: Times New roman, Size: 14, Bold).


Affiliation and Corresponding author: The full name of institutions and subsidiary departments should be given. The address of the institution should include the name of the institution, city, country. When a paper has several authors from different institutions, key the author to the address with superscript Arabic numerals (for detail please refer current issue papers). For two different addresses of one author, use different consecutive numbers e.g. 1,2 (as superscript).


Use the following format:

Priyanka Singh1*, Anjan Hazra2, Suparna Mondal Biswas2, Swati Chakraborty1, Sauren Das2, Nirjhar Dasgupta1.


1Department of Life Science, Guru Nanak Institute of Pharmaceutical Science and Technology, Kolkata, West Bengal, India, 2Agricultural and Ecological Research Unit, Indian Statistical Institute, Kolkata, West Bengal, India


*Corresponding Author: Priyanka Singh, Department of Life Science, Guru Nanak Institute of Pharmaceutical Science and Technology, Kolkata, West Bengal, India, Email:Prixxxx@gmail.com


Abstract: An abstract is a brief, comprehensive summary of the contents of the article; it allows readers to survey the contents of an article quickly. Abstract should be concise less than 250 words and describe, in a paragraph, concisely purpose, methods, important results and describe conclusion of the study, but not repeat information already presented in the title. Short communication or clinical case reports must also be submitted with an abstract.


Keywords: This is a list important terms relevant to the content of paper and should be different from title. Up to 4-5 keywords should be listed at the bottom of abstract to be used as index terms.


For Example:


Keywords: Azo dyes, Degradation, Heavy metals, Phanerochaete chrysosporium, Phenolics


Introduction: In this part no needs to write separate heading like ‘INTRODUCTION”. This is a brief background and limited to the statement of the importance of the study, problem or the aim of the experiment. It may briefly justify the research and specify the hypotheses to be tested. The review of literature should be pertinent to the problem. The specific questions to be addressed the study should also described. Objective of the study should be discussed in view of latest references.


Material and Methods: This section should deal with the materials used and the methodology (how the work was carried out). The procedure adopted should be described in sufficient details to allow the experiment to be interpreted and repeated by the readers, if desired. The number of subjects, the number of groups, the study design, sources of drugs with dosage regimen or instruments used, statistical methods and ethical aspects must be mentioned under the section. The data collection procedure must be described. If a procedure is a commonly used, giving a previously published reference would suffice. If a method is not well known (though previously published) it is better to describe it briefly. Give explicit descriptions of modifications or new methods so that the readers can judge their accuracy, reproducibility and reliability.


The nomenclature, the source of material and equipment used, with details of the manufacturer in parentheses, should be clearly mentioned. Drugs and chemicals should be precisely identified using their non-proprietary names or generic names. If necessary, the proprietary or commercial name may be inserted once in parentheses. The first letter of the drug name should be small for generic name (e.g., dipyridamole, propranolol) but capitalized for proprietary names (e.g., Persantin, Inderal). New or uncommon drug should be identified by the chemical name and structural formula.


Results and Discussion: The results should be stated concisely without comments. They should be presented in logical sequence in the text with appropriate reference to tables and/or figures. The data given in tables or figures should not be repeated in the text. The same data should not be presented in both tabular and graphic forms. Simple data may be given in the text itself instead of figures or tables.


In the Discussion section, should be deal with the interpretation, rather than recapitulation of results. It is important to discuss the new and significant observations in the light of previous work. Discuss also the weaknesses or pitfalls in the study. New hypotheses or recommendations can be put forth.


Avoid unqualified statements and conclusions not completely supported by the data. Repetition of information given under Introduction and Results should be avoided. Conclusions must be drawn considering the strengths and weaknesses of the study.


Acknowledgement: These should be typed on a new paragraph. Acknowledge only those who have contributed to the scientific content or provided technical support. Sources of financial support may be mentioned.

Tables and Figures:

Tables

• Tables should be self-explanatory and should not duplicate textual material.

• Tables with more than 10 columns and 25 rows are not acceptable.

• Number tables, in Arabic numerals, consecutively in the order of their first citation in the text and supply a brief title for each.

• For footnotes use the following symbols, in this sequence: *, †, ‡, §, ||,¶ , **, ††, ‡‡

• Tables with their legends should be provided at the end of the text after the references. The tables along with their number should be cited at the relevant place in the text


Figures

• Upload the images in JPEG format. The file size should be within 1024 kb in size while uploading.

• Figures should be numbered consecutively according to the order in which they have been first cited in the text.

• Labels, numbers, and symbols should be clear and of uniform size. The lettering for figures should be large enough to be legible after reduction to fit the width of a printed column.

• Titles and detailed explanations belong in the legends for illustrations not on the illustrations themselves.

• The photographs and figures should be trimmed to remove all the unwanted areas.

• If photographs of individuals are used, their pictures must be accompanied by written permission to use the photograph.

• If a figure has been published elsewhere, acknowledge the original source and submit written permission from the copyright holder to reproduce the material. A credit line should appear in the legend for such figures.

• Legends for illustrations: Type or print out legends (maximum 40 words, excluding the credit line) for illustrations using double spacing, with Arabic numerals corresponding to the illustrations. When symbols, arrows, numbers, or letters are used to identify parts of the illustrations, identify and explain each one in the legend. Explain the internal scale (magnification) and identify the method of staining in photomicrographs.

• The Journal reserves the right to crop, rotate, reduce, or enlarge the photographs to an acceptable size.


Important Note: Table and Figure number should be cite in the manuscript otherwise it will be rejected in the editorial review process.


Reference:

Tables

All the References should be in alphabetic Order. IJBBS Accepts Unnumbered references in the text. Use the style of the examples below.


The titles of journals should be abbreviated according to the style used in Index Medicus. Avoid using abstracts as references. Information from manuscripts submitted but not accepted should be cited in the text as "unpublished observations" with written permission from the source. Avoid citing a "personal communication" unless it provides essential information not available from a public source, in which case the name of the person and date of communication should be cited in parentheses in the text.


For standard journal abbreviations, please below links:
http://images.webofknowledge.com/WOK46/help/WOS/A_abrvjt.html
http://www.ncbi.nlm.nih.gov/sites/entrez?db=journals
Articles in Journals

Author(s), year. Title. Journal name (abbreviated and italic), volume number (bold) (Issue Number in Bracket): page-page.


Rudakiya, D., and Pawar, K. 2014. Bioremediation potential of Comamonas acidovorans MTCC 3364 for the removal of sulfonated di-azo dye Reactive Black B. Int. J Agri Env Biotech, 7(2):525-535.


Balamurugan, S., Divyabharathi, N., Jayashruthi, K., Bowiya, M.,Shermy, R.P. and Shanker, R. 2016. Internet of agriculture: Applying IoT to improve food and farming technology. Int. Res. J. Eng. Technol., 3(10), 713-719.


For whole books

Author(s), Year. Title. (Ed.).Edition if any, Publisher, address. Page number.


Babu, S.M., Lakshmi, A.J. and Rao, B.T. 2015. A Study on Cloud Based Internet of Things: Cloud IoT. In: 2015 Global Conference on Communication Technologies (GCCT), IEEE, Piscataway, New Jersey. pp. 60-65.


For chapters from books :


Author(s), year. Title. In: book title, editors (editors), Ed., Publisher, address. Page-page.


Sharma, N. 2011. Milk fever. In: Production diseases of dairy animals. Satish Serial Publication.pp 45-60.


For Symposium

Devegowda, G., Raju, M., Afzali, N. and Swamy H.V.L.N. 1998. Mycotoxin picture world-wide: Novel solutions for their counteraction. In: Proceedings of 7th Convention and Symposium of Indian Society for Veterinary Medicine. Feb, 2011. Bangalore, India. pp. 241-255.


Protection of Patients' Rights to Privacy

Identifying information should not be published in written descriptions, photographs, sonograms, CT scans, etc., and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian, wherever applicable) gives informed consent for publication. Authors should remove patients' names from figures unless they have obtained informed consent from the patients. The journal abides by ICMJE guidelines:


1) Authors, neither the journals nor the publisher, need to obtain the patient consent form before the publication and have the form properly archived. The consent forms are not to be uploaded with the cover letter or sent through email to editorial or publisher offices.


2) If the manuscript contains patient images that preclude anonymity, or a description that has obvious indication to the identity of the patient, a statement about obtaining informed patient consent should be indicated in the manuscript.


Sending a revised manuscript

The revised version of the manuscript should be submitted online in a manner similar to that used for submission of the manuscript for the first time. However, there is no need to submit the “First Page” or “Covering Letter” file while submitting a revised version. When submitting a revised manuscript, contributors are requested to include, the ‘referees’ remarks along with point to point clarification at the beginning in the revised file itself. In addition, they are expected to mark the changes as underlined or colored text in the article.


Process for sending the revised manuscript is completely online, you need to login your author portal and under the column of your article, you will find send back to editor. Use the same to upload your revised manuscript.


Note: If you face any problem while uploading the revised manuscript, you can email us at editor@intbioinformaticsjr.com or support@manuscriptsubmissionweb.com mentioning your Article Number starts with MS.

Manuscript Submission, Processing and Publication charges

Submission charges: The journal does not charge for submission.


Processing and Publication charges: The journal will charge fee on acceptance for case Report, Short communication, Editorial, Letter To Editor, Original Article, Review Article, for the publications. The fee will be 105$, and there is special fee (70$) for graduate students (For International Authors) and Rs 1500 (For Indian Authors).


@International Journal of Bioinformatics and Biological Sciences(IJBBS)| Printed by New Delhi Publishers

749395 - Visitors since March 19, 2020